These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
213 related items for PubMed ID: 12270248
1. Improved immune response from biodegradable polymer particles entrapping tetanus toxoid by use of different immunization protocol and adjuvants. Raghuvanshi RS, Katare YK, Lalwani K, Ali MM, Singh O, Panda AK. Int J Pharm; 2002 Oct 01; 245(1-2):109-21. PubMed ID: 12270248 [Abstract] [Full Text] [Related]
2. Potentiation of immune response from polymer-entrapped antigen: toward development of single dose tetanus toxoid vaccine. Katare YK, Panda AK, Lalwani K, Haque IU, Ali MM. Drug Deliv; 2003 Oct 01; 10(4):231-8. PubMed ID: 14612338 [Abstract] [Full Text] [Related]
3. Influence of particle size, antigen load, dose and additional adjuvant on the immune response from antigen loaded PLA microparticles. Katare YK, Muthukumaran T, Panda AK. Int J Pharm; 2005 Sep 14; 301(1-2):149-60. PubMed ID: 16023313 [Abstract] [Full Text] [Related]
4. Immunogenicity and lower dose requirement of polymer entrapped tetanus toxoid co-administered with alum. Katare YK, Panda AK. Vaccine; 2006 Apr 24; 24(17):3599-608. PubMed ID: 16513224 [Abstract] [Full Text] [Related]
5. Enhanced immune response with a combination of alum and biodegradable nanoparticles containing tetanus toxoid. Raghuvanshi RJ, Mistra A, Talwar GP, Levy RJ, Labhasetwar V. J Microencapsul; 2001 Apr 24; 18(6):723-32. PubMed ID: 11695637 [Abstract] [Full Text] [Related]
6. Influences of excipients on in vitro release and in vivo performance of tetanus toxoid loaded polymer particles. Katare YK, Panda AK. Eur J Pharm Sci; 2006 Jun 24; 28(3):179-88. PubMed ID: 16517132 [Abstract] [Full Text] [Related]
8. Formulation and characterization of immunoreactive tetanus toxoid biodegradable polymer particles. Raghuvanshi RS, Singh O, Panda AK. Drug Deliv; 2001 Jun 24; 8(2):99-106. PubMed ID: 11400869 [Abstract] [Full Text] [Related]
18. Single shot tetanus vaccine manufactured by a supercritical fluid encapsulation technology. Baxendale A, van Hooff P, Durrant LG, Spendlove I, Howdle SM, Woods HM, Whitaker MJ, Davies OR, Naylor A, Lewis AL, Illum L. Int J Pharm; 2011 Jul 15; 413(1-2):147-54. PubMed ID: 21554938 [Abstract] [Full Text] [Related]
19. Development of a single dose tetanus toxoid formulation based on polymeric microspheres: a comparative study of poly(D,L-lactic-co-glycolic acid) versus chitosan microspheres. Jaganathan KS, Rao YU, Singh P, Prabakaran D, Gupta S, Jain A, Vyas SP. Int J Pharm; 2005 Apr 27; 294(1-2):23-32. PubMed ID: 15814228 [Abstract] [Full Text] [Related]
20. Formulation, characterization and evaluation of rotavirus encapsulated PLA and PLGA particles for oral vaccination. Nayak B, Panda AK, Ray P, Ray AR. J Microencapsul; 2009 Mar 27; 26(2):154-65. PubMed ID: 18608800 [Abstract] [Full Text] [Related] Page: [Next] [New Search]